FDA Inspection 1019048 — Straumann USA LLC
The FDA completed an inspection of Straumann USA LLC on Jul 21, 2017 in Andover, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 21, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Andover, MA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12411 | 21 CFR 1271.260(a) | Contamination, mix ups, improper release |
| 12425 | 21 CFR 1271.265(c)(1) | Release of HCT/Ps by responsible person |
| 3130 | 21 CFR 820.100(a) | Lack of or inadequate procedures |
| 3375 | 21 CFR 820.198(e) | Records of complaint investigation |
| 4193 | 21 CFR 806.10(b) | Time to report - 10 days |
| 731 | 21 CFR 803.50(a)(1) | Report of Death or Serious Injury |